161 related articles for article (PubMed ID: 37290588)
1. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
[TBL] [Abstract][Full Text] [Related]
2. Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action.
Noordermeer T; Molhoek JE; Schutgens REG; Sebastian SAE; Drost-Verhoef S; van Wesel ACW; de Groot PG; Meijers JCM; Urbanus RT
J Thromb Haemost; 2021 Apr; 19(4):1018-1028. PubMed ID: 33421291
[TBL] [Abstract][Full Text] [Related]
3. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
5. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
[TBL] [Abstract][Full Text] [Related]
6. Double positivity of anti-β
Yun J; Gu J; Kim HK
J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240
[TBL] [Abstract][Full Text] [Related]
7. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
8. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.
Bradáčová P; Slavík L; Skoumalová A; Úlehlová J; Kriegová E; Manukyan G; Friedecký D; Piskláková B; Ullrychová J; Procházková J; Hluší A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012233
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance.
Pontara E; Cattini MG; Bison E; Cheng C; Denas G; Pengo V
Thromb Res; 2022 Oct; 218():17-23. PubMed ID: 35973396
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis.
Forastiero R; Martinuzzo M; Pombo G; Puente D; Rossi A; Celebrin L; Bonaccorso S; Aversa L
J Thromb Haemost; 2005 Jun; 3(6):1231-8. PubMed ID: 15946213
[TBL] [Abstract][Full Text] [Related]
11. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
Pregnolato F; Chighizola CB; Encabo S; Shums Z; Norman GL; Tripodi A; Chantarangkul V; Bertero T; De Micheli V; Borghi MO; Meroni PL
Immunol Res; 2013 Jul; 56(2-3):432-8. PubMed ID: 23572433
[TBL] [Abstract][Full Text] [Related]
12. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
Galli M; Ruggeri L; Barbui T
Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
[TBL] [Abstract][Full Text] [Related]
14. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
Nojima J; Kuratsune H; Suehisa E; Kawasaki T; Machii T; Kitani T; Iwatani Y; Kanakura Y
Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
[TBL] [Abstract][Full Text] [Related]
15. Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects.
Pontara E; Bison E; Cattini MG; Tonello M; Denas G; Pengo V
J Thromb Haemost; 2023 Nov; 21(11):3138-3144. PubMed ID: 37422199
[TBL] [Abstract][Full Text] [Related]
16. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system.
Wahl D; Membre A; Perret-Guillaume C; Regnault V; Lecompte T
Curr Rheumatol Rep; 2009 Feb; 11(1):77-81. PubMed ID: 19171115
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
19. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ; Griffin JH; Gale AJ
Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
